PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27166183-4	2016	In this study, we utilized a CHK1 inhibitor, LY2603618, to decrease Mcl-1 and enhance ABT-199 efficacy.	LY2603618	45-54	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	68-73	
27166183-6	2016	LY2603618 treatment resulted in decrease of Mcl-1, which coincided with the initiation of apoptosis.	LY2603618	0-9	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	44-49	
27166183-7	2016	Overexpression of Mcl-1 in AML cells significantly attenuated apoptosis induced by LY2603618, confirming the critical role of Mcl-1 in apoptosis induced by the agent.	LY2603618	83-92	MCL1 apoptosis regulator, BCL2 family member	Homo sapiens	18-23